- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
The fully-updated fifth edition covers the essential information required to become a neurobiologically empowered psychopharmacologist.
Andere Kunden interessierten sich auch für
- Stephen M. StahlStahl's Illustrated Mood Stabilizers59,99 €
- Ramzy Yassa / N. P. V. Nair / Dilip V. Jeste (eds.)Neuroleptic-Induced Movement Disorders135,99 €
- Perry W BuffingtonPsychopharmacology84,99 €
- Jahangir MoiniNeuropsychopharmacology210,99 €
- Stephen D SilbersteinEssential Neuropharmacology104,99 €
- Jerrold S. Meyer (Amherst University of Massachusetts)Psychopharmacology76,99 €
- Irene de CasoPsychedelics and Mental Health26,99 €
-
-
-
The fully-updated fifth edition covers the essential information required to become a neurobiologically empowered psychopharmacologist.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Cambridge University Press
- Revised edition
- Seitenzahl: 644
- Erscheinungstermin: 1. September 2022
- Englisch
- Abmessung: 247mm x 194mm x 37mm
- Gewicht: 1368g
- ISBN-13: 9781108992886
- ISBN-10: 1108992889
- Artikelnr.: 61498665
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: Cambridge University Press
- Revised edition
- Seitenzahl: 644
- Erscheinungstermin: 1. September 2022
- Englisch
- Abmessung: 247mm x 194mm x 37mm
- Gewicht: 1368g
- ISBN-13: 9781108992886
- ISBN-10: 1108992889
- Artikelnr.: 61498665
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
Stephen M Stahl, MD, PhD is Professor of Psychiatry and Neuroscience at UC Riverside and at UC San Diego, Honorary Visiting Senior Fellow, University of Cambridge, UK, and Chairman of the Neuroscience Education Institute, Carlsbad.
Preface to the Fifth Edition
CME Information
1. Chemical Neurotransmission
2. Transporters, Receptors and Enzymes as Targets of Psychopharmacological Drug Action
3. Ion Channels as Targets of Psychopharmacological Drug Action
4. Psychosis, Schizophrenia and the Neurotransmitter Networks Dopamine, Serotonin and Glutamate
5. Targeting Dopamine and Serotonin Receptors for Psychosis, Mood and Beyond: So-Called 'Antipsychotics'
6. Mood Disorders and the Neurotransmitter Networks Norepinephrine and Gamma Amino Butyric Acid (Gaba)
7. Treatments for Mood Disorders: So-Called 'Antidepressants' and 'Mood Stabilizers'
8. Anxiety, Trauma and Treatment
9. Chronic Pain and its Treatment
10. Disorders of Sleep and Wakefulness and their Treatment: Neurotransmitter Networks for Histamine and Orexin
11. Attention Deficit Hyperactivity Disorder and its Treatment
12. Dementia: Causes, Symptomatic Treatments and the Neurotransmitter Network Acetylcholine
13. Impulsivity, Compulsivity and Addiction
Suggested Reading and Selected References
Index.
CME Information
1. Chemical Neurotransmission
2. Transporters, Receptors and Enzymes as Targets of Psychopharmacological Drug Action
3. Ion Channels as Targets of Psychopharmacological Drug Action
4. Psychosis, Schizophrenia and the Neurotransmitter Networks Dopamine, Serotonin and Glutamate
5. Targeting Dopamine and Serotonin Receptors for Psychosis, Mood and Beyond: So-Called 'Antipsychotics'
6. Mood Disorders and the Neurotransmitter Networks Norepinephrine and Gamma Amino Butyric Acid (Gaba)
7. Treatments for Mood Disorders: So-Called 'Antidepressants' and 'Mood Stabilizers'
8. Anxiety, Trauma and Treatment
9. Chronic Pain and its Treatment
10. Disorders of Sleep and Wakefulness and their Treatment: Neurotransmitter Networks for Histamine and Orexin
11. Attention Deficit Hyperactivity Disorder and its Treatment
12. Dementia: Causes, Symptomatic Treatments and the Neurotransmitter Network Acetylcholine
13. Impulsivity, Compulsivity and Addiction
Suggested Reading and Selected References
Index.
Preface to the Fifth Edition
CME Information
1. Chemical Neurotransmission
2. Transporters, Receptors and Enzymes as Targets of Psychopharmacological Drug Action
3. Ion Channels as Targets of Psychopharmacological Drug Action
4. Psychosis, Schizophrenia and the Neurotransmitter Networks Dopamine, Serotonin and Glutamate
5. Targeting Dopamine and Serotonin Receptors for Psychosis, Mood and Beyond: So-Called 'Antipsychotics'
6. Mood Disorders and the Neurotransmitter Networks Norepinephrine and Gamma Amino Butyric Acid (Gaba)
7. Treatments for Mood Disorders: So-Called 'Antidepressants' and 'Mood Stabilizers'
8. Anxiety, Trauma and Treatment
9. Chronic Pain and its Treatment
10. Disorders of Sleep and Wakefulness and their Treatment: Neurotransmitter Networks for Histamine and Orexin
11. Attention Deficit Hyperactivity Disorder and its Treatment
12. Dementia: Causes, Symptomatic Treatments and the Neurotransmitter Network Acetylcholine
13. Impulsivity, Compulsivity and Addiction
Suggested Reading and Selected References
Index.
CME Information
1. Chemical Neurotransmission
2. Transporters, Receptors and Enzymes as Targets of Psychopharmacological Drug Action
3. Ion Channels as Targets of Psychopharmacological Drug Action
4. Psychosis, Schizophrenia and the Neurotransmitter Networks Dopamine, Serotonin and Glutamate
5. Targeting Dopamine and Serotonin Receptors for Psychosis, Mood and Beyond: So-Called 'Antipsychotics'
6. Mood Disorders and the Neurotransmitter Networks Norepinephrine and Gamma Amino Butyric Acid (Gaba)
7. Treatments for Mood Disorders: So-Called 'Antidepressants' and 'Mood Stabilizers'
8. Anxiety, Trauma and Treatment
9. Chronic Pain and its Treatment
10. Disorders of Sleep and Wakefulness and their Treatment: Neurotransmitter Networks for Histamine and Orexin
11. Attention Deficit Hyperactivity Disorder and its Treatment
12. Dementia: Causes, Symptomatic Treatments and the Neurotransmitter Network Acetylcholine
13. Impulsivity, Compulsivity and Addiction
Suggested Reading and Selected References
Index.